Company profile: Emboline
1.1 - Company Overview
Company description
- Provider of total embolic protection during percutaneous heart valve repair, offering the Emboliner Total Embolic Protection Catheter designed to capture and remove embolic debris to protect the brain and other organs.
Products and services
- Brain and Organ Embolic Debris Capture: A catheter-guided component architected to intercept and remove embolic particles during valve repair, shielding the brain and other organs
- Emboliner Total Embolic Protection Catheter: A catheter-based device engineered to capture and remove embolic debris during percutaneous heart valve repair, delivering protection for the brain and other organs
- Total Embolic Protection During Percutaneous Heart Valve Repair: A percutaneous-specific system that captures and removes embolic debris throughout valve repair, safeguarding the brain and other organs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Emboline
Pherin
HQ: United States
Website
- Description: Provider of clinical-stage investigational drugs for psychiatric and neurological disorders, particularly anxiety and depression, developing pherines (a new class of drugs) and an oral antagonist targeting the glycine site of the N-methyl-D-aspartate receptor (NMDAR). Privately held.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pherin company profile →
Link Medicine
HQ: United States
Website
- Description: Provider of research aimed at creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Link Medicine company profile →
Xanodyne
HQ: United States
Website
- Description: Provider of integrated specialty pharmaceutical products, developing and commercializing offerings in women's healthcare and pain management in the United States.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xanodyne company profile →
NeuroReality
HQ: The Netherlands
Website
- Description: Provider of VR-based cognitive rehabilitation and brain training solutions using neuroscience and gamification. Offers Koji's Quest, a patient-centric SaaS VR game for recovery from brain injuries, connecting clinicians and patients to improve outcomes and enable superior care. Organizes clinical trials to evaluate effectiveness and prepares Koji's Quest for individual self-training via the Oculus Quest store.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroReality company profile →
Openwater
HQ: United States
Website
- Description: Provider of a medical technology system focused on treating diseases at the cellular level.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Openwater company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Emboline
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Emboline
2.2 - Growth funds investing in similar companies to Emboline
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Emboline
4.2 - Public trading comparable groups for Emboline
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →